Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Aventis Allegra Inventory Stable At Two Weeks; Price Flexibility “Minimal”

Executive Summary

Aventis' inventory levels for Allegra have stabilized following first quarter wholesaler reductions triggered by the availability of OTC Claritin, VP-Investor Relations Arvind Sood told investors June 29
Advertisement

Related Content

Wholesalers “Secure” Despite Changes In Inventory Practices, Cardinal Says
Allegra DTC Ads Include Comparative Claims Against Zyrtec, OTCs
Wholesalers “Secure” Despite Changes In Inventory Practices, Cardinal Says
Allegra DTC Ads Include Comparative Claims Against Zyrtec, OTCs
Allegra Hurt By Stocking, Late Allergy Season, Not Other Products – Aventis
Allegra Hurt By Stocking, Late Allergy Season, Not Other Products – Aventis
Aventis Allegra New Prescriptions Up 9% Despite Availability Of OTC Claritin  
Allegra Growth Expected At 20% Annually; Generic Impact Possible In 2004
Advertisement
UsernamePublicRestriction

Register

PS042225

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel